OTLK logo

OTLKOutlook Therapeutics Inc

$0.8083
$0.0053
(0.65%)
Today
Updated: 03:58 PM EDT
Reported EarningsMay 15
Mkt Cap$98.33M
Vol9.63M

About

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
17

Frequently Asked Questions

What is Market Cap of Outlook Therapeutics Inc?
What is the 52-week high for Outlook Therapeutics Inc?
What is the 52-week low for Outlook Therapeutics Inc?
What is Outlook Therapeutics Inc stock price today?
What was Outlook Therapeutics Inc stock price yesterday?
What is the PE ratio of Outlook Therapeutics Inc?
What is the Price-to-Book ratio of Outlook Therapeutics Inc?
What is the 50-day moving average of Outlook Therapeutics Inc?
How many employees does Outlook Therapeutics Inc have?